Itou, Tatsuo
Fujita, Koji
Okuzono, Yuumi
Warude, Dnyaneshwar
Miyakawa, Shuuichi
Mihara, Yoshimi
Matsui, Naoko
Morino, Hiroyuki
Kikukawa, Yusuke
Izumi, Yuishin
Funding for this research was provided by:
Takeda Pharmaceutical Company (NA)
Ministry of Health, Labour and Welfare (JPMH23FC1008)
Article History
Received: 1 October 2024
Accepted: 18 December 2024
First Online: 27 December 2024
Declarations
:
: All study protocols were approved by the Ethics Committee of Tokushima University Hospital under protocol #3682. All clinical information was collected after patients provided written informed consent. The investigations were conducted following the principles of the Declaration of Helsinki.
: Not applicable.
: TI, YO, DW, SM, and YK are employees of Takeda Pharmaceutical Company Limited.